Diagnosis and management of postoperative ileal pouch disorders

Clinics in Colon and Rectal Surgery

Volumn 23, Issue 4, 2010, Pages 259-268

  Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Complication; ileal pouch; inflammatory bowel disease; restorative proctocolectomy

Indexed keywords

EID: 78650113739     PISSN: 15310043     EISSN: 15309681     Source Type: Journal    
DOI: 10.1055/s-0030-1268252     Document Type: Article

References (103)

1. Hueting W E., Buskens E, van der Tweel I, Gooszen H G., van Laarhoven C J. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dig Surg 2005 22 (1-2) 69-79
2. Sagap I, Remzi F H., Hammel J P., Fazio V W. Factors associated with failure in managing pelvic sepsis after ileal pouch-anal anastomosis (IPAA)a multivariate analysis. Surgery 2006 140 (4) 691-703 discussion 703-704
3. Prudhomme M, Dehni N, Dozois R R., Tiret E, Parc R. Causes and outcomes of pouch excision after restorative proctocolectomy. Br J Surg 2006 93 (1) 82-86
4. Nicholls R J. Review article: ulcerative colitissurgical indications and treatment. Aliment Pharmacol Ther 2002 16 (Suppl 4) 25-28
5. Shen B, Lian L, Remzi F H. et al. Natural history of cuffitis in ulcerative colitis patients with restorative proctocolectomy and ileal pouch-anal anastomosis. Poster presented at: Digestive Disease Week May 110, 2010 New Orleans, LA
6. Garrett K A., Remzi F H., Kirat H T., Fazio V W., Shen B, Kiran R P. Outcome of salvage surgery for ileal pouches referred with a diagnosis of Crohn's disease. Dis Colon Rectum 2009 52 (12) 1967-1974
7. Paye F, Penna C, Chiche L, Tiret E, Frileux P, Parc R. Pouch-related fistula following restorative proctocolectomy. Br J Surg 1996 83 (11) 1574-1577
8. Hedrick T L., Sawyer R G., Foley E F., Friel C M. Anastomotic leak and the loop ileostomy: friend or foe? Dis Colon Rectum 2006 49 (8) 1167-1176
9. Meagher A P., Farouk R, Dozois R R., Kelly K A., Pemberton J H. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998 85 (6) 800-803
10. Tang L, Cai H, Moore L, Shen B. Evaluation of endoscopic and imaging modalities in the diagnosis of structural disorders of the ileal pouch. Inflamm Bowel Dis 2010 16 (9) 1526-1531
11. Swain B T., Ellis C N. Fibrin glue treatment of low rectal and pouch-anal anastomotic sinuses. Dis Colon Rectum 2004 47 (2) 253-255
12. Whitlow C B., Opelka F G., Gathright J B. Jr, Beck D E. Treatment of colorectal and ileoanal anastomotic sinuses. Dis Colon Rectum 1997 40 (7) 760-763
13. Lian L, Geisler D, Shen B. Endoscopic needle knife treatment of chronic presacral sinus at the anastomosis at an ileal pouch-anal anastomosis. Endoscopy 2010 42 (Suppl 2) E14
14. Shah N S., Remzi F, Massmann A, Baixauli J, Fazio V W. Management and treatment outcome of pouch-vaginal fistulas following restorative proctocolectomy. Dis Colon Rectum 2003 46 (7) 911-917
15. Rochey H, Navaneethan U, Kiran R, Shen B. Evaluation of diagnostic modalities for pouch vaginal fistula in patients with inflammatory bowel disease and restorative proctocolectomy. Paper presented at: American College of Gastroenterology Annual Meeting October 1820, 2010 San Antonio,TX
16. Burke D, van Laarhoven C J., Herbst F, Nicholls R J. Transvaginal repair of pouch-vaginal fistula. Br J Surg 2001 88 (2) 241-245
17. Prudhomme M, Dozois R R., Godlewski G, Mathison S, Fabbro-Peray P. Anal canal strictures after ileal pouch-anal anastomosis. Dis Colon Rectum 2003 46 (1) 20-23
18. Shen B, Fazio V W., Remzi F H. et al. Endoscopic balloon dilation of ileal pouch strictures. Am J Gastroenterol 2004 99 (12) 2340-2347
19. Lucha P A. Jr, Fticsar J E., Francis M J. The strictured anastomosis: successful treatment by corticosteroid injectionsreport of three cases and review of the literature. Dis Colon Rectum 2005 48 (4) 862-865
20. Shen B, Fazio V W., Remzi F H. et al. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol 2005 100 (1) 93-101
21. Penna C, Dozois R, Tremaine W et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996 38 (2) 234-239 (Pubitemid 26046819)
22. Fazio V W., Ziv Y, Church J M. et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995 222 (2) 120-127
23. Gionchetti P, Rizzello F, Helwig U et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003 124 (5) 1202-1209
24. Penna C, Tiret E, Kartheuser A, Hannoun L, Nordlinger B, Parc R. Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis. Br J Surg 1993 80 (6) 765-767 (Pubitemid 23197736)
25. Tjandra J J., Fazio V W., Church J M., Oakley J R., Milsom J W., Lavery I C. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis. Am J Surg 1993 165 (3) 322-325
26. Gosselink M P., Schouten W R., van Lieshout L MC, Hop W C., Laman J D., Ruseler-van Embden J G. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis Colon Rectum 2004 47 (6) 876-884
27. Gionchetti P, Rizzello F, Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 (2) 305-309
28. Mimura T, Rizzello F, Helwig U et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004 53 (1) 108-114
29. Carter M J., Di Giovine F S., Cox A et al. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 2001 121 (4) 805-811
30. Brett P M., Yasuda N, Yiannakou J Y. et al. Genetic and immunological markers in pouchitis. Eur J Gastroenterol Hepatol 1996 8 (10) 951-955
31. Aisenberg J, Legnani P E., Nilubol N et al. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol 2004 99 (3) 432-441
32. Meier C B., Hegazi R A., Aisenberg J et al. Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor? Inflamm Bowel Dis 2005 11 (11) 965-971
33. Schmidt C M., Lazenby A J., Hendrickson R J., Sitzmann J V. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998 227 (5) 654-662 discussion 663-665
34. Achkar J P., Al-Haddad M, Lashner B et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005 3 (1) 60-66
35. Okon A, Dubinsky M, Vasiliauskas E A. et al. Elevated platelet count before ileal pouch-anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitis. Am Surg 2005 71 (10) 821-826
36. Fleshner P, Ippoliti A, Dubinsky M et al. A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2007 5 (8) 952-958, quiz 887
37. Shepherd N A., Hultén L, Tytgat G NJ et al. Pouchitis. Int J Colorectal Dis 1989 4 (4) 205-229
38. Lohmuller J L., Pemberton J H., Dozois R R., Ilstrup D, van Heerden J. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990 211 (5) 622-627 discussion 627-629
39. Hata K, Watanabe T, Shinozaki M, Nagawa H. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol 2003 38 (10) 1055-1058
40. Fleshner P R., Vasiliauskas E A., Kam L Y. et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001 49 (5) 671-677
41. Kuisma J, Järvinen H, Kahri A, Färkkilä M. Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 2004 39 (6) 544-548
42. Hui T, Landers C, Vasiliauskas E et al. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation. Dis Colon Rectum 2005 48 (6) 1254-1262
43. Merrett M N., Mortensen N, Kettlewell M, Jewell D O. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 1996 38 (3) 362-364
44. Shen B, Fazio V W., Remzi F H. et al. Risk factors for diseases of ileal pouch-anal anastomosis in patients with ulcerative colitis. Clin Gastroenterol Hepatol 2006 4 81-89 (Pubitemid 43129528)
45. Shen B, Achkar J-P, Lashner B A. et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001 121 (2) 261-267
46. Moskowitz R L., Shepherd N A., Nicholls R J. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986 1 (3) 167-174
47. Sandborn W J. Pouchitis: risk factors, frequency, natural history, classification and public health prospective In: Me Leod RS, Martin F, Sutherland LR, Wallace JL, Williams CN Trends in Inflammatory Bowel Disease 1996. Lancaster, UK Kluwer Academic Publishers 1997 51-63
48. Shen B, Remzi F H., Lavery I C., Lashner B A., Fazio V W. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol 2008 6 (2) 145-158 quiz 124
49. Shen B. Diagnosis and treatment of patients with pouchitis. Drugs 2003 63 (5) 453-461
50. Shen B O., Jiang Z-D, Fazio V W. et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008 6 (7) 782-788
51. Kühbacher T, Ott S J., Helwig U et al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006 55 (6) 833-841
52. Muñoz-Juarez M, Pemberton J H., Sandborn W J., Tremaine W J., Dozois R R. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum 1999 42 (1) 117-120
53. Moonka D, Furth E E., MacDermott R P., Lichtenstein G R. Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol 1998 93 (2) 264-266
54. Shen B. Campylobacter infection in patients with ileal pouches. Am J Gastroenterol 2010 105 (2) 472-473
55. Shen B, Fazio V W., Bennett A E. et al. Effect of withdrawal of non-steroidal anti-inflammatory drug use in patients with the ileal pouch. Dig Dis Sci 2007 52 3321-3328
56. Shen B, Remzi F H., Nutter B et al. Association between immune-associated disorders and adverse outcomes of ileal pouch-anal anastomosis. Am J Gastroenterol 2009 104 (3) 655-664
57. Shen B, Plesec T P., Remer E et al. Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis? Inflamm Bowel Dis 2010 16 (5) 836-846
58. Nicholls R J. Review article: ulcerative colitissurgical indications and treatment. Aliment Pharmacol Ther 2002 16 (Suppl 4) 25-28
59. Madden M V., McIntyre A S., Nicholls R J. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994 39 (6) 1193-1196
60. Shen B, Achkar J P., Lashner B A. et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001 7 (4) 301-305
61. Araki Y, Mitsuyama K, Nagae T et al. Leukocytapheresis for the treatment of active pouchitis: a pilot study. J Gastroenterol 2008 43 (7) 571-575
62. Gionchetti P, Rizzello F, Morselli C et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 2007 50 (12) 2075-2082, discussion 20822084
63. Shen B, Pardi D S., Bennett A E. et al. The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis. Am J Gastroenterol 2009 104 (6) 1468-1474
64. Gionchetti P, Rizzello F, Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 (2) 305-309
65. Mimura T, Rizzello F, Helwig U et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004 53 (1) 108-114
66. Shen B, Remzi F H., Lopez A R., Queener E. Rifaximin for maintenance therapy in antibiotic-dependent pouchitis. BMC Gastroenterol 2008 8 26 [electronic journal]
67. Shen B, Brzezinski A, Fazio V W. et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther 2005 22 (8) 721-728
68. Gionchetti P, Rizzello F, Venturi A et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999 13 (6) 713-718
69. Abdelrazeq A S., Kelly S M., Lund J N., Leveson S H. Rifaximin- ciprofloxacin combination therapy is effective in chronic active refractory pouchitis. Colorectal Dis 2005 7 (2) 182-186
70. Mimura T, Rizzello F, Helwig U et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002 16 (5) 909-917
71. Shen B, Fazio V W., Remzi F H. et al. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Colon Rectum 2007 50 (4) 498-508
72. Viscido A, Kohn A, Papi C, Caprilli R. Management of refractory fistulizing pouchitis with infliximab. Eur Rev Med Pharmacol Sci 2004 8 (5) 239-246
73. Tremaine W J., Sandborn W J., Wolff B G., Carpenter H A., Zinsmeister A R., Metzger P P. Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997 11 (6) 1041-1046
74. Wischmeyer P, Pemberton J H., Phillips S F. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993 68 (10) 978-981
75. Gionchetti P, Rizzello F, Poggioli G et al. Oral budesonide in the treatment of chronic refractory pouchitis. Aliment Pharmacol Ther 2007 25 (10) 1231-1236
76. Calabrese C, Gionchetti P, Rizzello F et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther 2008 27 (9) 759-764
77. Shen B, Lashner B A., Bennett A E. et al. Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis. Am J Gastroenterol 2004 99 (8) 1527-1531
78. Shen B, Lian L, Remzi F H. et al. Natural history of cuffitis in ulcerative colitis patients with restorative proctocolectomy and ileal pouch-anal anastomosis. Poster presented at: Digestive Diseases Week May 15, 2010 New Orleans, LA
79. Panis Y, Poupard B, Nemeth J, Lavergne A, Hautefeuille P, Valleur P. Ileal pouch/anal anastomosis for Crohn's disease. Lancet 1996 347 (9005) 854-857 (Pubitemid 26099536)
80. Melton G B., Fazio V W., Kiran R P. et al. Long-term outcomes with ileal pouch-anal anastomosis and Crohn's disease: pouch retention and implications of delayed diagnosis. Ann Surg 2008 248 (4) 608-616
81. Shen B. Crohn's disease of the ileal pouch: reality, diagnosis, and management. Inflamm Bowel Dis 2009 15 (2) 284-294
82. Shen B, Patel S, Lian L. Natural history of Crohn's disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis. Aliment Pharmacol Ther 2010 31 (7) 745-753
83. Melmed G Y., Fleshner P R., Bardakcioglu O et al. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2008 51 (1) 100-108
84. Shen B, Remzi F H., Hammel J P. et al. Family history of Crohn's disease is associated with an increased risk for Crohn's disease of ileal pouch-anal anastomosis. Inflamm Bowel Dis 2009 15 163-170
85. Nasseri Y, Melmed G, Wang H L., Targan S, Fleshner P. Rigorous histopathological assessment of the colectomy specimen in patients with inflammatory bowel disease unclassified does not predict outcome after ileal pouch-anal anastomosis. Am J Gastroenterol 2010 105 (1) 155-161
86. Shen B, Fazio V W., Remzi F H. et al. Risk factors for clinical phenotypes of Crohn's disease of the ileal pouch. Am J Gastroenterol 2006 101 (12) 2760-2768
87. Colombel J-F, Ricart E, Loftus E V. Jr, et al. Management of Crohn's disease of the ileoanal pouch with infliximab. Am J Gastroenterol 2003 98 (10) 2239-2244
88. Shen B, Fazio V W., Remzi F H. et al. Endoscopic balloon dilation of ileal pouch strictures. Am J Gastroenterol 2004 99 (12) 2340-2347
89. Matzke G M., Kang A S., Dozois E J., Sandborn W J. Mid pouch strictureplasty for Crohn's disease after ileal pouch-anal anastomosis: an alternative to pouch excision. Dis Colon Rectum 2004 47 (5) 782-786
90. Shen B, Remzi F H., Lavery I C. et al. Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch. Aliment Pharmacol Ther 2009 29 (5) 519-526
91. Shen B, Achkar J-P, Lashner B A. et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002 97 (4) 972-977
92. Shen B, Sanmiguel C, Bennett A E. et al. Irritable pouch syndrome is characterized by visceral hypersensitivity. Inflamm Bowel Dis 2010 Aug 3 [Epub ahead of print]
93. Shen B, Liu W, Remzi F H. et al. Enterochromaffin cell hyperplasia in irritable pouch syndrome. Am J Gastroenterol 2008 103 (9) 2293-2300
94. Freeman H. Dysplasia-associated polypoid mucosal lesion in a pelvic pouch after restorative proctocolectomy for ulcerative colitis. Can J Gastroenterol 2001 15 (7) 485-488
95. Negi S S., Chaudhary A, Gondal R. Carcinoma of pelvic pouch following restorative proctocolectomy: report of a case and review of the literature. Dig Surg 2003 20 (1) 63-65
96. Laureti S, Ugolini F, D'Errico A, Rago S, Poggioli G. Adenocarcinoma below ileoanal anastomosis for ulcerative colitis: report of a case and review of the literature. Dis Colon Rectum 2002 45 (3) 418-421
97. Hyman N. Rectal cancer as a complication of stapled IPAA. Inflamm Bowel Dis 2002 8 (1) 43-45
98. Das P, Johnson M W., Tekkis P P., Nicholls R J. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Colorectal Dis 2007 9 (1) 15-27
99. Sarigol S, Wyllie R, Gramlich T et al. Incidence of dysplasia in pelvic pouches in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis. J Pediatr Gastroenterol Nutr 1999 28 (4) 429-434
100. Veress B, Reinholt F P., Lindquist K, Löfberg R, Liljeqvist L. Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 1995 109 (4) 1090-1097
101. Heuschen U A., Hinz U, Allemeyer E H. et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 2001 120 (4) 841-847
102. Gullberg K, Ståhlberg D, Liljeqvist L et al. Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology 1997 112 (5) 1487-1492
103. Kariv R, Remzi F H., Lian L et al. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy. Gastroenterology 2010 139 (3) 806-812 812, e1-e2